The journal of prevention of Alzheimer's disease
Published

Class-level aggregation obscures clinically relevant heterogeneity in anti-amyloid antibody trials: comments on a Cochrane review by individual members of the EADC

Authors

Kristian Steen Frederiksen, Mercè Boada, Lutz Frölich, Milica Kramberger, Nikolaos Scarmeas, Everard Vijverberg, Pieter Jelle Visser, Gunhild Waldemar, Eric Westman, Henrik Zetterberg, Sebastiaan Engelborghs, Frank Jessen
Read More

Abstract

J Prev Alzheimers Dis. 2026 May 18;13(7):100598. doi: 10.1016/j.tjpad.2026.100598. Online ahead of print.

NO ABSTRACT

PMID:42150345 | DOI:10.1016/j.tjpad.2026.100598

UK DRI Authors

Prof Henrik Zetterberg

Group Leader

Pioneering the development of fluid biomarkers for dementia

Prof Henrik Zetterberg